166 related articles for article (PubMed ID: 38315244)
21. Predictors of quality of life in 102 patients with treated Cushing's disease.
Carluccio A; Sundaram NK; Chablani S; Amrock LG; Lambert JK; Post KD; Geer EB
Clin Endocrinol (Oxf); 2015 Mar; 82(3):404-11. PubMed ID: 24931777
[TBL] [Abstract][Full Text] [Related]
22. Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment.
Buliman A; Tataranu LG; Paun DL; Mirica A; Dumitrache C
J Med Life; 2016; 9(1):12-18. PubMed ID: 27974908
[TBL] [Abstract][Full Text] [Related]
23. The role of bilateral adrenalectomy in the treatment of refractory Cushing's disease.
Wong A; Eloy JA; Liu JK
Neurosurg Focus; 2015 Feb; 38(2):E9. PubMed ID: 25639327
[TBL] [Abstract][Full Text] [Related]
24. Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment.
Braun LT; Rubinstein G; Zopp S; Vogel F; Schmid-Tannwald C; Escudero MP; Honegger J; Ladurner R; Reincke M
Endocrine; 2020 Nov; 70(2):218-231. PubMed ID: 32743767
[TBL] [Abstract][Full Text] [Related]
25. Cushing's disease in children: report of three cases.
Hsu PY; Tung YC; Lee CT; Lo FS; Wu MZ; Tsai WY; Tu YK
Pediatr Neonatol; 2010 Oct; 51(5):303-7. PubMed ID: 20951363
[TBL] [Abstract][Full Text] [Related]
26. The quality of life in adult patients treated for Cushing's disease in childhood.
Pasternak-Pietrzak K; Moszczyńska E; Szalecki M
Pediatr Endocrinol Diabetes Metab; 2021; 27(2):93-99. PubMed ID: 34514766
[TBL] [Abstract][Full Text] [Related]
27. Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.
van der Pas R; de Bruin C; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Webb SM; Lamberts SW; Hofland LJ; Feelders RA
Pituitary; 2013 Dec; 16(4):536-44. PubMed ID: 23225121
[TBL] [Abstract][Full Text] [Related]
28. Management of Cushing's disease: a single-center experience.
Solak M; Kraljevic I; Dusek T; Melada A; Kavanagh MM; Peterkovic V; Ozretic D; Kastelan D
Endocrine; 2016 Mar; 51(3):517-23. PubMed ID: 26215278
[TBL] [Abstract][Full Text] [Related]
29. Demographic factors, outcomes, and patient access to transsphenoidal surgery for Cushing's disease: analysis of the Nationwide Inpatient Sample from 2002 to 2010.
Wilson D; Jin DL; Wen T; Carmichael JD; Cen S; Mack WJ; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E2. PubMed ID: 25639320
[TBL] [Abstract][Full Text] [Related]
30. Current management of Cushing's disease.
Tritos NA; Biller BMK
J Intern Med; 2019 Nov; 286(5):526-541. PubMed ID: 31512305
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of pediatric Cushing's disease.
Savage MO; Storr HL; Chan LF; Grossman AB
Pituitary; 2007; 10(4):365-71. PubMed ID: 17570065
[TBL] [Abstract][Full Text] [Related]
32. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R; Fleseriu M; Newell-Price J; Bertagna X; Findling J; Shimatsu A; Gu F; Auchus R; Leelawattana R; Lee EJ; Kim JH; Lacroix A; Laplanche A; O'Connell P; Tauchmanova L; Pedroncelli AM; Biller BMK;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):748-761. PubMed ID: 32730798
[TBL] [Abstract][Full Text] [Related]
34. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract][Full Text] [Related]
35. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
Guaraldi F; Zoli M; Asioli S; Corona G; Gori D; Friso F; Pasquini E; Bacci A; Sforza A; Mazzatenta D
J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.
Bengtsson D; Ragnarsson O; Berinder K; Dahlqvist P; Edén Engström B; Ekman B; Höybye C; Burman P; Wahlberg J
J Clin Endocrinol Metab; 2021 May; 106(6):1750-1760. PubMed ID: 33567076
[TBL] [Abstract][Full Text] [Related]
38. Psychometric evaluation of the Cushing's Quality-of-Life questionnaire.
Nelson LM; Forsythe A; McLeod L; Pulgar S; Maldonado M; Coles T; Zhang Y; Webb SM; Badia X
Patient; 2013; 6(2):113-24. PubMed ID: 23575965
[TBL] [Abstract][Full Text] [Related]
39. Posttraumatic stress symptoms (PTSS) in patients with Cushing's disease before and after surgery: A prospective study.
Chen Z; Wang G; Jiang C
J Clin Neurosci; 2019 Aug; 66():1-6. PubMed ID: 31178305
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing's Syndrome.
Frete C; Corcuff JB; Kuhn E; Salenave S; Gaye D; Young J; Chanson P; Tabarin A
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32594169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
